Your browser doesn't support javascript.
loading
Regorafenib for Metastatic Colorectal Cancer: An Analysis of a Registry-Based Cohort of 555 Patients.
Novakova-Jiresova, Alena; Kopeckova, Katerina; Boublikova, Ludmila; Chloupkova, Renata; Melichar, Bohuslav; Petruzelka, Lubos; Finek, Jindrich; Fiala, Ondrej; Grell, Peter; Batko, Stanislav; Linke, Zdenek; Kiss, Igor; Prausova, Jana; Buchler, Tomas.
Afiliação
  • Novakova-Jiresova A; Department of Oncology, First Faculty of Medicine and Thomayer Hospital, Charles University, Prague, Czech Republic.
  • Kopeckova K; Department of Oncology, University Hospital in Motol, Charles University, Prague, Czech Republic.
  • Boublikova L; Department of Oncology, First Faculty of Medicine and Thomayer Hospital, Charles University, Prague, Czech Republic.
  • Chloupkova R; Institute of Biostatistics and Analysis, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Melichar B; Department of Oncology, Palacky University Medical and Teaching Hospital, Olomouc, Czech Republic.
  • Petruzelka L; Department of Oncology, General Faculty Hospital, Charles University, Prague, Czech Republic.
  • Finek J; Department of Oncology and Radiotherapy, Medical School and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.
  • Fiala O; Department of Oncology and Radiotherapy, Medical School and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.
  • Grell P; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
  • Batko S; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Linke Z; Department of Oncology, University Hospital in Motol, Charles University, Prague, Czech Republic.
  • Kiss I; Department of Oncology, University Hospital in Motol, Charles University, Prague, Czech Republic.
  • Prausova J; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Buchler T; Department of Oncology, University Hospital in Motol, Charles University, Prague, Czech Republic.
Cancer Manag Res ; 12: 5365-5372, 2020.
Article em En | MEDLINE | ID: mdl-32753954

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article